我国血液制品企业GMP检查缺陷分析及监管思路探索
Defect Analysis of GMP Inspection of Blood Product Enterprises and Suggestions on Supervision in China
{{custom_ref.label}} |
{{custom_citation.content}}
{{custom_citation.annotation}}
|
/
〈 |
|
〉 |